Produktbild: Advances in Statistical Methods for the Health Sciences
- 13%

Advances in Statistical Methods for the Health Sciences Applications to Cancer and AIDS Studies, Genome Sequence Analysis, and Survival Analysis

13% sparen

171,99 € UVP 197,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2006

Herausgeber

Jean-Louis Auget + weitere

Verlag

Birkhäuser Boston

Seitenzahl

540

Maße (L/B/H)

26/18,5/3,5 cm

Gewicht

1124 g

Auflage

2007 edition

Sprache

Englisch

ISBN

978-0-8176-4368-3

Beschreibung

Rezension

From the reviews:



"This edited volume is an outgrowth of an ‘International Conference on Statistical Methods’ so-called in the Health Sciences in 2004. It is a well presented volume with lists of tables and figures. … Clearly this volume covers a wide range of topics pertaining to statistical methods in the area of health sciences. … In summary, it is a welcome addition to the literature of statistical science." (Technometrics, Vol. 49 (3), August, 2007)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2006

Herausgeber

Verlag

Birkhäuser Boston

Seitenzahl

540

Maße (L/B/H)

26/18,5/3,5 cm

Gewicht

1124 g

Auflage

2007 edition

Sprache

Englisch

ISBN

978-0-8176-4368-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Advances in Statistical Methods for the Health Sciences
  • Preface Contributors List of Tables List of Figures Part I: Prognostic Studies and General Epidemiology Systematic Review of Multiple Studies of Prognosis: The Feasibility of Obtaining Individual Patient Data \ D.G. Altman, M. Trivella, F. Pezzella, and A.L. Harris On Statistical Approaches for the Multivariate Analysis of Prognostic Marker Studies \ N. Holländer and W. Sauerbrei Where Next for Evidence Synthesis of Prognostic Marker Studies? Improving the Quality and Reporting of Primary Studies to Facilitate Clinically Relevant Evidence-Based Results \ R.D. Riley, K.R. Abrams, P.C. Lambert, A.J. Sutton, and D.G. Altman Part II: Pharmacovigilance Sentinel Event Methods for Monitoring Unanticipated Adverse Events \ P.A. Lachenbruch and J. Wittes Spontaneous Reporting System Modelling for the Evaluation of Automatic Signal Generation Methods in Pharmacovigilance \ E. Roux, F. Thiessard, A. Fourier, B. Bégaud, and P. Tubert-Bitter Part III: Quality of Life Latent Covariates in Generalized Linear Models: A Rasch Model Approach \ K.B. Christensen Sequential Analysis of Quality of Life Measurements with the Mixed Partial Credit Model \ V. Sébille, T. Challa, and M. Mesbah A Parametric Degradation Model Used in Reliability, Survival Analysis, and Quality of Life \ M. Nikulin, L. Gerville-Réache, and S. Orazio Agreement Between Two Ratings with Different Ordinal Scales \ S. Natarajan, M.B. McHenry, S. Lipsitz, N. Klar, and S. Lipshultz Part IV: Survival Analysis The Role of Correlated Frailty Models in Studies of Human Health, Ageing, and Longevity \ A. Wienke, P. Lichtenstein, K. Czene, and A.I. Yashin Prognostic Factors and Prediction of Residual Survival for Hospitalized Elderly Patients \ M.L. Calle, P. Roura, A. Arnau, A. Yáñez, and A.Leiva New Models and Methods for Survival Analysis of Experimental Data \ G.V. Semenchenko, A.I. Yashin, T.E. Johnson, and J.W. Cypser Uniform Consistency for Conditional Lifetime Distribution Estimators Under Random Right-Censorhip \ P. Deheuvels and G. Derzko Sequential Estimation for the Semiparametric Additive Hazard Model \ L. Bordes and C. Breuils Variance Estimation of a Survival Function with Doubly Censored Failure Time Data \ C. Zhu and J. Sun Part V: Clustering Statistical Models and Artificial Neural Networks: Supervised Classification and Prediction Via Soft Trees \ A. Ciampi and Y. Lechevallier Multilevel Clustering for Large Databases \ Y. Lechevallier and A. Ciampi Neural Networks: An Application for Predicting Smear Negative Pulmonary Tuberculosis \ A.M. Santos, B.B. Pereira, J.M. Seixas, F.C.Q. Mello, and A.L. Kritski Assessing Drug Resistance in HIV Infection Using Viral Load Using Segmented Regression \ H. Liang, W.-Y. Tan, and X. Xiong Assessment of Treatment Effects on HIV Pathogenesis Under Treatment by State Space Models \ W.-Y. Tan, P. Zhang, X. Xiong, and P. Flynn Part VI: Safety and Efficacy Assessment Safety Assessment Versus Efficacy Assessment \ M.A. Foulkes Cancer Clinical Trials with Efficacy and Toxicity Endpoints: A Simulation Study to Compare Two Nonparametric Methods \ A. Letierce and P. Tubert-Bitter Safety Assessment in Pilot Studies When Zero Events are Observed \ R.E. Carter and R.F. Woolson Part VII: Clinical Designs An Assessment of Up-and-Down Designs and Associated Estimators in Phase I Trials \ H.K.T. Ng, S.G. Mohanty, and N. Balakrishnan Design of Multicentre Clinical Trials with Random Enrolment \ V.V. Anisimov and V.V. Fedorov Statistical Methods for Combining Clinical Trial Phases II and III \ N. Stallard and S. Tod